Home Biotechnology Industry News Top 50 Opportunities for Generic Pharmaceutical Companies Assessed in…

Top 50 Opportunities for Generic Pharmaceutical Companies Assessed in…

New research study “Prioritizing Generic Drug development pipeline – The top Fifty Opportunities” developed by MP Advisors has been recently published by Market Publishers Ltd.

(PRWeb August 20, 2012)

Read the full story at http://www.prweb.com/releases/2012/8/prweb9817421.htm